Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins

Nature Reviews Genetics

Volumn 8, Issue 10, 2007, Pages 735-748

  Wang, Weidong ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; BUTADIENE DIEPOXIDE; CHECKPOINT KINASE RAD3; CISPLATIN; DNA; FANCONI ANEMIA PROTEIN; MITOMYCIN C;

ATAXIA TELANGIECTASIA; BREAST CANCER; CELL CYCLE S PHASE; CHROMOSOME ABERRATION; DIAGNOSTIC PROCEDURE; DNA DAMAGE; DNA REPAIR; DNA STRUCTURE; EVOLUTION; FANCONI ANEMIA; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOPRECIPITATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GENE; UBIQUITINATION;

ANIMALS; BRCA2 PROTEIN; CHROMATIN; DNA; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; NUCLEAR PROTEINS; RNA HELICASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

ATAXIA TELANGIECTASIA;

EID: 34548759123     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2159     Document Type: Review

References (106)

1. Garcia-Higuera, I. et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7, 249-262 (2001). This work presents the first evidence for a DNA-damage response pathway that includes FA proteins and BRCA1, and shows that FANCD2 monoubiquitylation is a key step in this pathway.
2. Howlett, N. G. et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297, 606-609 (2002). This study showed that BRCA2 is identical to FANCD1, providing the first direct evidence for a connection between breast cancer and FA.
3. Wang, X., Andreassen, P. R. & D'Andrea, A. D. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell. Biol. 24, 5850-5862 (2004).
4. Venkitaraman, A. R. Tracing the network connecting BRCA and Fanconi anaemia proteins. Nature Rev. Cancer 4, 266-276 (2004).
5. Levitus, M. et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nature Genet. 37, 934-935 (2005). One of the three papers that identified the BRCA1-interacting helicase BRIP1 as FANCJ, thus providing new connections between FA and breast cancer, and between FA and DNA repair.
6. Levran, O. et al. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nature Genet. 37, 931-933 (2005).
7. Litman, R. et al. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8, 255-265 (2005).
8. Xia, B. et al. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nature Genet. 39, 159-161 (2007). One of the two papers that identified the BRCA2 partner PALB2 as the protein that is defective in FA complementation group N, providing a new connection between FA and breast cancer.
9. Reid, S. et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nature Genet. 39, 162-164 (2007).
10. Rahman, N. et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nature Genet. 39, 165-167 (2007).
11. Meetei, A. R. et al. A human ortholog of archaeal DNA repair protein HEF is defective in Fanconi anemia complementation group M. Nature Genet. 37, 958-963 (2005). This study showed that FANCM is an orthologue of archaeal DNA-repair protein Hef with DNA-processing domains and activity, thus providing a direct connection between FA and DNA repair.
12. Mosedale, G. et al. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nature Struct. Mol. Biol. 12, 763-771 (2005).
13. Pichierri, P. & Rosselli, F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J. 23, 1178-1187 (2004).
14. Andreassen, P. R., D'Andrea, A. D. & Taniguchi, T. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev. 18, 1958-1963 (2004).
15. Yamamoto, K. et al. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol. Cell. Biol. 23, 5421-5430 (2003).
16. Niedzwiedz, W. et al. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol. Cell 15, 607-620 (2004).
17. Nakanishi, K. et al. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl Acad. Sci. USA 102, 1110-1115 (2005).
18. Fanconi, G. Familiaere infantile perniziosaartige Anaemie (pernizioeses Blutbild and konstitution). Jahrbuch Kinderheild 117, 257-280 (1927) (in German).
19. Joenje, H. & Patel, K. J. The emerging genetic and molecular basis of fanconi anaemia. Nature Rev. Genet. 2, 446-459 (2001).
20. Levitus, M., Joenje, H. & de Winter, J. P. The Fanconi anemia pathway of genomic maintenance. Cell Oncol. 28, 3-29 (2006).
21. Akkari, Y. M. et al. The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase. Mol. Genet. Metab. 74, 403-412. (2001).
22. Dronkert, M. L. & Kanaar, R. Repair of DNA interstrand cross-links. Mutat. Res. 486, 217-247 (2001).
23. Li, L., Peterson, C. A., Lu, X., Wei, P. & Legerski, R. J. Interstrand cross-links induce DNA synthesis in damaged and undamaged plasmids in mammalian cell extracts. Mol. Cell. Biol. 19, 5619-5630 (1999).
24. Hirano, S. et al. Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM. EMBO J. 24, 418-427 (2005).
25. Meetei, A. R. et al. A multiprotein nuclear complex connects Fanconi anemia and bloom syndrome. Mol. Cell. Biol. 23, 3417-3426 (2003). This study provided the first evidence for a complex containing both FA and BLM proteins, leading to the subsequent discovery of three new FA genes (FANCL, FANCB and FANCM) and two novel proteins (FAAP100 and BLAP75) as essential for the FA pathway and BLM functions.
26. Ciccia, A. et al. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol. Cell 25, 331-443 (2007).
27. Ling, C. et al. FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J. 26, 2104-2114 (2007).
28. Yin, J. et al. BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity. EMBO J. 24, 1465-1476 (2005).
29. Kennedy, R. D. & D'Andrea, A. D. The Fanconi anemia/BRCA pathway: new faces in the crowd. Genes Dev. 19, 2925-2940 (2005).
30. Taniguchi, T. et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nature Med. 9, 568-574 (2003). This study revealed that the FA-BRCA pathway can be disrupted by epigenetic silencing in several ovarian cancer cell lines, suggesting that this pathway is involved in sporadic cancers of non-FA individuals.
31. van der Heijden, M. S., Yeo, C. J., Hruban, R. H. & Kern, S. E. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res. 63, 2585-2588 (2003).
32. Condie, A. et al. Analysis of the Fanconi anaemia complementation group A gene in acute myeloid leukaemia. Leuk. Lymphoma 43, 1849-1853 (2002).
33. Tischkowitz, M. D. et al. Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia. Leukemia 18, 420-425 (2004).
34. Turner, N., Tutt, A. & Ashworth, A. Hallmarks of 'BRCAness' in sporadic cancers. Nature Rev. Cancer 4, 814-819 (2004).
35. Chirnomas, D. et al. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Mol. Cancer Ther. 5, 952-961 (2006).
36. Strathdee, C. A., Gavish, H., Shannon, W. R. & Buchwald, M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356, 763-767 (1992). This study used a new functional complementation assay to clone the first FA gene, FANCC.
37. Strathdee, C. A., Duncan, A. M. & Buchwald, M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nature Genet. 1, 196-198 (1992).
38. Lo Ten Foe, J. R. et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nature Genet. 14, 320-323 (1996).
39. Apostolou, S. et al. Positional cloning of the Fanconi anaemia group A gene. The Fanconi anaemia/breast cancer consortium. Nature Genet. 14, 324-328 (1996).
40. de Winter, J. P. et al. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nature Genet. 20, 281-283 (1998).
41. de Winter, J. P. et al. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nature Genet. 24, 15-16 (2000).
42. de Winter, J. P. et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet. 67, 1306-1308 (2000).
43. Kupfer, G. M., Naf, D., Suliman, A., Pulsipher, M. & D'Andrea, A. D. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex. Nature Genet. 17, 487-490 (1997).
44. de Winter, J. P. et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet. 9, 2665-2674 (2000).
45. Medhurst, A. L., Huber, P. A., Waisfisz, Q., de Winter, J. P. & Mathew, C. G. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum. Mol. Genet. 10, 423-429 (2001).
46. Timmers, C. et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell 7, 241-248 (2001).
47. Taniguchi, T. et al. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100, 2414-2420 (2002).
48. Smogorzewska, A. et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129, 289-301 (2007). One of the three papers that identified FANCI as a paralogue of FANCD2. This work also showed that FANCI is a ubiquitylation substrate for the FA core complex and works together with FANCD2 as the ID complex.
49. Dorsman, J. C. et al. Identification of the Fanconi anemia complementation group I gene, FANCI. Cell Oncol. 29, 211-218 (2007).
50. Sims, A. E. et al. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nature Struct. Mol. Biol. 14, 564-567 (2007).
51. Meetei, A. R. et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nature Genet. 35, 165-170 (2003). This study identified FANCL as an E3 ubiquitin ligase that is essential for FANCD2 monoubiquitylation.
52. Garcia-Higuera, I., Kuang, Y., Naf, D., Wasik, J. & D'Andrea, A. D. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol. Cell. Biol. 19, 4866-4873 (1999).
53. Meetei, A. R. et al. X-linked inheritance of Fanconi anemia complementation group B. Nature Genet. 36, 1219-1224 (2004).
54. Xia, B. et al. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell 22, 719-729 (2006).
55. Gurtan, A. M., Stuckert, P. & D'Andrea, A. D. The WD40 repeats of FANCL are required for Fanconi anemia core complex assembly. J. Biol. Chem. 281, 10896-10905 (2006).
56. Pace, P. et al. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 21, 3414-3423 (2002).
57. Komori, K., Fujikane, R., Shinagawa, H. & Ishino, Y. Novel endonuclease in Archaea cleaving DNA with various branched structure. Genes Genet. Syst. 77, 227-241 (2002).
58. Komori, K. et al. Cooperation of the N-terminal Helicase and C-terminal endonuclease activities of Archaeal Hef protein in processing stalled replication forks. J. Biol. Chem. 279, 53175-53185 (2004).
59. Prakash, R. et al. Saccharomyces cerevisiae MPH1 gene, required for homologous recombination-mediated mutation avoidance, encodes a 3′ to 5′ DNA helicase. J. Biol. Chem. 280, 7854-7860 (2005).
60. Sobeck, A., Stone, S. & Hoatlin, M. E. DNA Structure-induced recruitment and activation of the Fanconi anemia pathway protein, FANCD2. Mol. Cell. Biol. 27, 4283-4292 (2007).
61. Yamashita, T. et al. The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. Proc. Natl Acad. Sci. USA 95, 13085-13090 (1998).
62. Qiao, F. et al. Phosphorylation of Fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway. J. Biol. Chem. 279, 46035-46045 (2004).
63. Wang, X. et al. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol. Cell. Biol. 27, 3098-3108 (2007).
64. Matsuoka, S. et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316, 1160-1166 (2007).
65. Nijman, S. M. et al. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17, 331-339 (2005).
66. Taniguchi, T. et al. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109, 459-472 (2002).
67. Park, W. H. et al. Direct DNA binding activity of the Fanconi anemia D2 protein. J. Biol. Chem. 280, 23593-23598 (2005).
68. Meetei, A. R., Yan, Z. & Wang, W. FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. Cell Cycle 3, 179-181 (2004).
69. Matsushita, N. et al. A FANCD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. Mol. Cell 19, 841-847 (2005).
70. Bogliolo, M. et al. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J. 26, 1340-1351 (2007).
71. Nojima, K. et al. Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Cancer Res. 65, 11704-11711 (2005).
72. McHugh, P. J. & Sarkar, S. DNA interstrand cross-link repair in the cell cycle: a critical role for polymerase ? in G1 phase. Cell Cycle 5, 1044-1047 (2006).
73. Shen, X. et al. REV3 and REV1 play major roles in recombination-independent repair of DNA interstrand cross-links mediated by monoubiquitinated proliferating cell nuclear antigen (PCNA). J. Biol. Chem. 281, 13869-13872 (2006).
74. Kannouche, P. L., Wing, J. & Lehmann, A. R. Interaction of human DNA polymerase η with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol. Cell 14, 491-500 (2004).
75. Kalb, R. et al. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am. J. Hum. Genet. 80, 895-910 (2007).
76. Houghtaling, S. et al. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev. 17, 2021-2035 (2003).
77. Godthelp, B. C. et al. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Mutat. Res. 594, 39-48 (2005).
78. Greenberg, R. A., Sobhian, B., Pathania, S., Cantor, S. B., Nakatani, Y. & Livingston, D. M. Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. Genes Dev. 20, 34-46 (2006).
79. Kim, H., Chen, J. & Yu, X. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science 316, 1202-1205 (2007).
80. Sobhian, B. et al. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science 316, 1198-1202 (2007).
81. Wang, B. et al. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 316, 1194-1198 (2007).
82. Peng, M. et al. The FANCJ/MutLα interaction is required for correction of the cross-link response in FA-J cells. EMBO J. 26, 3238-3249 (2007).
83. Sharan, S. K. et al. Embryonic lethality and radiation hypersensitivity mediated by RAD51 in mice lacking BRCA2. Nature 386, 804-810 (1997).
84. Yang, H. et al. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297, 1837-1848. (2002).
85. Pellegrini, L. et al. Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nature 420, 287-293 (2002).
86. Moynahan, M. E., Pierce, A. J. & Jasin, M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell 7, 263-272 (2001).
87. Yuan, S. S. et al. BRCA2 is required for ionizing radiation-induced assembly of RAD51 complex in vivo. Cancer Res. 59, 3547-3551 (1999).
88. Bridge, W. L., Vandenberg, C. J., Franklin, R. J. & Hiom, K. The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nature Genet. 37, 953-957 (2005).
89. Cantor, S. et al. The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proc. Natl Acad. Sci. USA 101, 2357-2362 (2004).
90. Seki, M., Marini, F. & Wood, R. D. POLQ (pol θ), a DNA polymerase and DNA-dependent ATPase in human cells. Nucleic Acids Res. 31, 6117-6126 (2003).
91. Harris, P. V. et al. Molecular cloning of Drosophila mus308, a gene involved in DNA cross-link repair with homology to prokaryotic DNA polymerase I genes. Mol. Cell. Biol. 16, 5764-5771 (1996).
92. Shima, N., Munroe, R. J. & Schimenti, J. C. The mouse genomic instability mutation chaos1 is an allele of POLQ that exhibits genetic interaction with ATM. Mol. Cell. Biol. 24, 10381-10389 (2004).
93. Guy, C. P. & Bolt, E. L. Archaeal Hel308 helicase targets replication forks in vivo and in vitro and unwinds lagging strands. Nucleic Acids Res. 33, 3678-3690 (2005).
94. Sobeck, A. et al. Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks. Mol. Cell. Biol. 26, 425-437 (2006).
95. Nakanishi, K. et al. Interaction of FANCD2 and NBS1 in the DNA damage response. Nature Cell Biol. 4, 913-920 (2002).
96. Stiff, T. et al. NBS1 is required for ATR-dependent phosphorylation events. EMBO J. 24, 199-208 (2005).
97. Collis, S. J. et al. HCLK2 is essential for the mammalian S-phase checkpoint and impacts on CHK1 stability. Nature Cell Biol. 9, 391-401 (2007).
98. Ho, G. P., Margossian, S., Taniguchi, T. & D'Andrea, A. D. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Mol. Cell. Biol. 26, 7005-7015 (2006).
99. Cobb, J. A., Bjergbaek, L., Shimada, K., Frei, C. & Gasser, S. M. DNA polymerase stabilization at stalled replication forks requires Mec1 and the RecQ helicase Sgs1. EMBO J. 22, 4325-4336 (2003).
100. Bjergbaek, L., Cobb, J. A., Tsai-Pflugfelder, M. & Gasser, S. M. Mechanistically distinct roles for Sgs1p in checkpoint activation and replication fork maintenance. EMBO J. 24, 405-417 (2005).
101. Thompson, L. H., Hinz, J. M., Yamada, N. A. & Jones, N. J. How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery. Environ. Mol. Mutagen. 45, 128-142 (2005).
102. Machida, Y. J. et al. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol. Cell 23, 589-596 (2006).
103. Huang, T. T. et al. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nature Cell Biol. 8, 339-347 (2006).
104. Niedernhofer, L. J., Lalai, A. S. & Hoeijmakers, J. H. Fanconi anemia (cross)linked to DNA repair. Cell 123, 1191-1198 (2005).
105. Kuraoka, I. et al. Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease. J. Biol. Chem. 275, 26632-26636 (2000).
106. Hanada, K. et al. The structure-specific endonuclease MUS81-EME1 promotes conversion of interstrand DNA crosslinks into double-strands breaks. EMBO J. 25, 4921-4932 (2006).